Dexamethasone	Placebo	Matrix metalloproteinases in cerebrospinal fluid in early treatment	819	947	Dexamethasone significantly reduced CSF MMP-9 concentrations in early follow up samples (median 5 days (range 3â€“8) of treatment)
Dexamethasone	Placebo	Baseline TIMP-2	9109	9320	Baseline pre-treatment concentrations of MMPs and TIMPs are summarized in table 2 and are similar between the two groups with the exception of TIMP-2, which was significantly higher in the patients give placebo.
